mhurhangee/ep-ind-claims huggingface dataset:
An EMI shielding gasket (12; 14) for compressible placement between a first aircraft surface and a second aircraft surface for providing electrical conductivity and deflection characteristics therebetween, the gasket (12; 14) comprising: a polymer elastomer gel layer, said gel layer having a gel layer outer margin extending along an x-axis and a y-axis, said y-axis disposed generally normal to the x-axis, at least a portion of the gel layer outer margin extending beyond a mesh outer margin, and extending beyond at least one of the first or second aircraft surfaces when the gasket is compressed, to define an edge portion tapered in an outwardly extended direction, said edge portion having a durometer higher than the durometer of the remainder of the gel; and a resilient, electrically-conductive mesh sheet (2; 18) embedded in the elastomer gel layer, the mesh (2; 18) having the mesh outer margin extending along the x-axis and the y-axis, and having a thickness dimension extending along a z-axis, said z-axis disposed generally normal to the x-axis and the y-axis, the mesh sheet (2; 18) being corrugated to form a series of waveforms having amplitudes extending generally along the z-axis, whereby when the gasket (12; 14) is compressed between the first and the second aircraft surfaces, the mesh sheet (2; 18) provides electrical conductivity across the direction of the x-axis and the y-axis, and electrical contact and improved force deflection between the first and the second aircraft surfaces in the direction of the z-axis. a polymer elastomer gel layer, said gel layer having a gel layer outer margin extending along an x-axis and a y-axis, said y-axis disposed generally normal to the x-axis, at least a portion of the gel layer outer margin extending beyond a mesh outer margin, and extending beyond at least one of the first or second aircraft surfaces when the gasket is compressed, to define an edge portion tapered in an outwardly extended direction, said edge portion having a durometer higher than the durometer of the remainder of the gel; and a resilient, electrically-conductive mesh sheet (2; 18) embedded in the elastomer gel layer, the mesh (2; 18) having the mesh outer margin extending along the x-axis and the y-axis, and having a thickness dimension extending along a z-axis, said z-axis disposed generally normal to the x-axis and the y-axis, the mesh sheet (2; 18) being corrugated to form a series of waveforms having amplitudes extending generally along the z-axis, whereby when the gasket (12; 14) is compressed between the first and the second aircraft surfaces, the mesh sheet (2; 18) provides electrical conductivity across the direction of the x-axis and the y-axis, and electrical contact and improved force deflection between the first and the second aircraft surfaces in the direction of the z-axis.
A method of making a coated article, the method comprising: - screen-printing a frit in a desired pattern on a glass substrate supporting a heat treatable thin-film coating formed by a multilayer low-emissivity (low-E) coating, wherein the low-E coating comprises at least one infrared reflecting layer sandwiched between first and second dielectric layers or layer stacks, and further supporting at least a portion of the frit lying over and directly contacting the low-E coating; - heat treating the substrate with the thin-film coating and the frit thereon in connection with a first temperature or first temperature range sufficient to (a) cause particles in the frit to migrate downwardly into the thin-film coating and dissolve the low-E coating in areas lying under the pattern, and - (b) fuse the frit directly to the substrate, in the desired pattern, in making the coated article. - screen-printing a frit in a desired pattern on a glass substrate supporting a heat treatable thin-film coating formed by a multilayer low-emissivity (low-E) coating, wherein the low-E coating comprises at least one infrared reflecting layer sandwiched between first and second dielectric layers or layer stacks, and further supporting at least a portion of the frit lying over and directly contacting the low-E coating; - heat treating the substrate with the thin-film coating and the frit thereon in connection with a first temperature or first temperature range sufficient to (a) cause particles in the frit to migrate downwardly into the thin-film coating and dissolve the low-E coating in areas lying under the pattern, and (a) cause particles in the frit to migrate downwardly into the thin-film coating and dissolve the low-E coating in areas lying under the pattern, and - (b) fuse the frit directly to the substrate, in the desired pattern, in making the coated article.
A process for producing corrugated fiberboard from plies of paper which each have a grammage of 70 to 200 g/m 2 and of which at least one ply of paper is obtained by a process comprising the addition of 0.25 to 5 wt%, based on dry paper stock, of at least one cationic polymer comprising vinylamine units, and 0 to 5 wt%, based on dry paper stock, of at least one polymeric anionic compound, to a paper stock, draining the paper stock by sheet formation, coating the paper web obtained with 0.1 to 3 wt%, based on dry paper stock, of at least one starch and drying the coated paper web, wherein the polymeric anionic compound is selected from a polymeric anionic compound and a polymeric anionic compound, wherein said polymeric anionic compound is obtainable by copolymerizing a monomer mixture comprising (a) at least one monomer selected from acrylamide and an N-vinylcarboxamide of the formula (b) where R 1 and R 2 are each H or C 1 to C 6 alkyl, and (c) at least one acid-functional monoethylenically unsaturated monomer and/or its alkali metal, alkaline earth metal or ammonium salts, and (d) optionally one or more monoethylenically unsaturated compounds other than said monomers (a) and (b), and (e) optionally one or more compounds having at least two ethylenically unsaturated double bonds in the molecule, and said polymeric anionic compound is the hydrolysis product of said polymeric anionic compound whose carboxamide moieties have been partly or wholly hydrolyzed into amino groups. 0.25 to 5 wt%, based on dry paper stock, of at least one cationic polymer comprising vinylamine units, and 0 to 5 wt%, based on dry paper stock, of at least one polymeric anionic compound, 0.1 to 3 wt%, based on dry paper stock, of at least one starch (a) at least one monomer selected from acrylamide and an N-vinylcarboxamide of the formula (b) where R 1 and R 2 are each H or C 1 to C 6 alkyl, and (c) at least one acid-functional monoethylenically unsaturated monomer and/or its alkali metal, alkaline earth metal or ammonium salts, and (d) optionally one or more monoethylenically unsaturated compounds other than said monomers (a) and (b), and (e) optionally one or more compounds having at least two ethylenically unsaturated double bonds in the molecule,
A compound of formula I wherein Z is N; wherein D is selected from linear or branched hydrocarbon groups having a carbon chain of from 1 to 6 carbon atoms, wherein R 1 is selected from: wherein - - - denotes the point of attachment wherein each of R 2 to R 6 is independently selected from -H, NO 2, halo, -CN, -N[(C=O) 0-1 R 12][(C=O) 0-1 R 13] and -(CH 2) 0-1 R 14, or two adjacent groups of R 2 to R 6, together with the carbon atoms to which they are attached, form a benzene ring, wherein at least one of R 2 to R 6 is -CN, wherein at least one of R 2 to R 6 is -(CH 2) 0-1 R 14 wherein R 12 and R 13 are independently selected from H, linear or branched hydrocarbon groups having a carbon chain of from 1 to 10 carbon atoms, or together with the atoms to which they are attached, may form a mono or bicyclic ring having from 5 to 14 ring members wherein R 14 is wherein - - - denotes the point of attachment wherein each of R 17 to R 21 is independently selected from -H, NO 2, halo, -O-(C 1 -C 6)haloalkyl, (C 1 -C 6)haloalkyl, (C 1 -C 6)alkyl, -CN, -OH, -OPh, -OBn, -Ph, -OSO 2 NR 15 R 16, and -O-(C 1 -C 6)alkyl; wherein each of R 7 to R 11 is independently selected from -H, halo, (C 1 -C 6)alkyl, - OH, and -OSO 2 NR 15 R 16; wherein R 15 and R 16 are independently selected from H, alkyl, cycloalkyl, alkenyl, acyl and aryl, or combinations thereof, or together represent alkylene, wherein the or each alkyl or cycloalkyl or alkenyl optionally contain one or more hetero atoms or groups; or any pharmaceutically acceptable salts thereof. wherein Z is N; wherein D is selected from linear or branched hydrocarbon groups having a carbon chain of from 1 to 6 carbon atoms, wherein R 1 is selected from: wherein - - - denotes the point of attachment wherein each of R 2 to R 6 is independently selected from -H, NO 2, halo, -CN, -N[(C=O) 0-1 R 12][(C=O) 0-1 R 13] and -(CH 2) 0-1 R 14, or two adjacent groups of R 2 to R 6, together with the carbon atoms to which they are attached, form a benzene ring, wherein at least one of R 2 to R 6 is -CN, wherein at least one of R 2 to R 6 is -(CH 2) 0-1 R 14 wherein R 12 and R 13 are independently selected from H, linear or branched hydrocarbon groups having a carbon chain of from 1 to 10 carbon atoms, or together with the atoms to which they are attached, may form a mono or bicyclic ring having from 5 to 14 ring members wherein R 14 is wherein - - - denotes the point of attachment wherein each of R 17 to R 21 is independently selected from -H, NO 2, halo, -O-(C 1 -C 6)haloalkyl, (C 1 -C 6)haloalkyl, (C 1 -C 6)alkyl, -CN, -OH, -OPh, -OBn, -Ph, -OSO 2 NR 15 R 16, and -O-(C 1 -C 6)alkyl; wherein each of R 7 to R 11 is independently selected from -H, halo, (C 1 -C 6)alkyl, - OH, and -OSO 2 NR 15 R 16; wherein R 15 and R 16 are independently selected from H, alkyl, cycloalkyl, alkenyl, acyl and aryl, or combinations thereof, or together represent alkylene, wherein the or each alkyl or cycloalkyl or alkenyl optionally contain one or more hetero atoms or groups;
An inflatable flotation device (200, 812) for use with an aircraft comprising: an inflatable body (201, 814) configured to be stored in a deflated state and to be inflated in response to an event, having a proximate end that is nearest to the aircraft during inflation, a distal end that is farthest from the aircraft during inflation, and two sides that each connect the proximate end to the distal end; a switch attached to the inflatable body and configured to switch from an off state to an on state in response to the inflatable body being inflated to or beyond a predetermined inflation level; a battery (802, 900) positioned on or in the inflatable body (201, 814) and configured to store electrical energy; and a speaker (310, 806) attached to the inflatable body, electrically coupled to the switch and to the battery, and configured to generate an audio signal indicating that the inflatable body is ready for use in response to the switch being switched from the off state to the on state, wherein the switch is an activation lanyard (401, 701, 800) positioned on the distal end of the inflatable body, having a base portion (402, 804) positioned within or attached to the battery and a detachable portion (404, 808) attached to a second location on the inflatable body such that the detachable portion remains attached to the base portion until the inflatable body is inflated to or beyond the predetermined inflation level and the activation lanyard switches to the on state in response to the detachable portion being detached from the base portion. an inflatable body (201, 814) configured to be stored in a deflated state and to be inflated in response to an event, having a proximate end that is nearest to the aircraft during inflation, a distal end that is farthest from the aircraft during inflation, and two sides that each connect the proximate end to the distal end; a switch attached to the inflatable body and configured to switch from an off state to an on state in response to the inflatable body being inflated to or beyond a predetermined inflation level; a battery (802, 900) positioned on or in the inflatable body (201, 814) and configured to store electrical energy; and a speaker (310, 806) attached to the inflatable body, electrically coupled to the switch and to the battery, and configured to generate an audio signal indicating that the inflatable body is ready for use in response to the switch being switched from the off state to the on state, wherein the switch is an activation lanyard (401, 701, 800) positioned on the distal end of the inflatable body, having a base portion (402, 804) positioned within or attached to the battery and a detachable portion (404, 808) attached to a second location on the inflatable body such that the detachable portion remains attached to the base portion until the inflatable body is inflated to or beyond the predetermined inflation level and the activation lanyard switches to the on state in response to the detachable portion being detached from the base portion.
A method of wireless communication, the method comprising: enabling, by a network equipment, multi-channel access when single operator operations cannot be guaranteed within a shared communication spectrum; defining, by the network equipment, a primary channel and a secondary channel within the shared communication channel; transmitting, by the network equipment, a configuration message to one or more low-radio frequency, RF, user equipments, UEs,, wherein the configuration message configures the one or more low-RF UEs to monitor the primary channel for a successful listen before talk, LBT, indicator; performing, by the network equipment, an LBT procedure on the primary channel and the secondary channel; and signaling, by the network equipment, the one or more low-RF UEs on the primary channel to re-tune to the secondary channel for communication during a current transmission opportunity in response to success of the LBT procedures on both the primary and secondary channels. enabling, by a network equipment, multi-channel access when single operator operations cannot be guaranteed within a shared communication spectrum; defining, by the network equipment, a primary channel and a secondary channel within the shared communication channel; transmitting, by the network equipment, a configuration message to one or more low-radio frequency, RF, user equipments, UEs,, wherein the configuration message configures the one or more low-RF UEs to monitor the primary channel for a successful listen before talk, LBT, indicator; performing, by the network equipment, an LBT procedure on the primary channel and the secondary channel; and signaling, by the network equipment, the one or more low-RF UEs on the primary channel to re-tune to the secondary channel for communication during a current transmission opportunity in response to success of the LBT procedures on both the primary and secondary channels.
A method for identifying a patient who is eligible to an intensification of heart failure therapy, said method comprising the steps of (a) measuring the level of at least one marker selected from the group consisting of creatinine, urea, sodium, glucose, HbAlc (glycated hemoglobin), hemoglobin, and hematocrit in a sample from a patient who has heart failure and who receives BNP-type peptide guided heart failure therapy, (b) comparing the level (or levels) of the marker (or markers) measured in (a) to a reference level (or reference levels), and (c) identifying a patient who is eligible to an intensification of heart failure therapy, or not. (a) measuring the level of at least one marker selected from the group consisting of creatinine, urea, sodium, glucose, HbAlc (glycated hemoglobin), hemoglobin, and hematocrit in a sample from a patient who has heart failure and who receives BNP-type peptide guided heart failure therapy, (b) comparing the level (or levels) of the marker (or markers) measured in (a) to a reference level (or reference levels), and (c) identifying a patient who is eligible to an intensification of heart failure therapy, or not.
A method for quantitation of one or more biomolecules in a sample, the method comprising the steps of: (a) providing a sample holder comprising a porous membrane which comprises a hydrophilic region surrounded by a hydrophobic region for sample containment, wherein the hydrophobic region is created either by plasma treatment of a hydrophilic porous membrane or wherein the hydrophobic region is created by heat treatment of a hydrophilic porous membrane; (b) contacting the hydrophilic region of the membrane with a sample volume, wherein the hydrophilic region has a diameter; (c) drying the sample volume on the membrane; and (d) exposing the sample volume on the membrane to an infrared beam having a diameter equal to or larger than the diameter of the hydrophilic region, and comprising a wavelength in the spectral range of 4000-400 cm -1 or any portion of the spectral range of 4000-400 cm -1, thereby to obtain an infrared absorption spectrum; wherein one or more absorption peak areas in the infrared absorption spectrum correlates with the quantity of the one or more biomolecules in the sample. (a) providing a sample holder comprising a porous membrane which comprises a hydrophilic region surrounded by a hydrophobic region for sample containment, wherein the hydrophobic region is created either by plasma treatment of a hydrophilic porous membrane or wherein the hydrophobic region is created by heat treatment of a hydrophilic porous membrane; (b) contacting the hydrophilic region of the membrane with a sample volume, wherein the hydrophilic region has a diameter; (c) drying the sample volume on the membrane; and (d) exposing the sample volume on the membrane to an infrared beam having a diameter equal to or larger than the diameter of the hydrophilic region, and comprising a wavelength in the spectral range of 4000-400 cm -1 or any portion of the spectral range of 4000-400 cm -1, thereby to obtain an infrared absorption spectrum;
A process for obtaining Everolimus, said process comprising acts of: a) adding triflic anhydride to a mixture of Sirolimus, 2-(t-butyldimethylsilyl)ethylene glycol, and a base in an organic solvent, to obtain crude 40-O-[2-(t-butyldimethylsilyl)oxy]ethyl rapamycin in a one pot conversion; and b) treating and purifying the crude 40-0-[2-(t-butyldimethylsilyl)oxy] ethyl rapamycin to obtain Everolimus, wherein the treating is carried out using methanol and a cationic resin selected from the group comprising SK110, UBK558 and/or T42H. a) adding triflic anhydride to a mixture of Sirolimus, 2-(t-butyldimethylsilyl)ethylene glycol, and a base in an organic solvent, to obtain crude 40-O-[2-(t-butyldimethylsilyl)oxy]ethyl rapamycin in a one pot conversion; and b) treating and purifying the crude 40-0-[2-(t-butyldimethylsilyl)oxy] ethyl rapamycin to obtain Everolimus,
Hair styling accessory for shaping hair, configured to be connected to an air outlet of a blown air hair styling device, said accessory comprising: - a hollow body provided with an end configured to be connected to said air outlet, - two hollow branches (9, 10) which extend the hollow body by branching off and which each comprise at least one opening, - said openings being configured to eject blown air into a direction, substantially perpendicular to a plane P passing through the two branches (9, 10), and which cut the two branches by extending parallel to the latter, - said branches being configured such that the ends (12, 13) thereof between them have a clearance E making it possible for the passing of hair, characterised in that it comprises bristles (14, 14a, 14b) which extend over the inner sides (9a, 10a) of the branches (9, 10), preferably parallel to the plane P. - a hollow body provided with an end configured to be connected to said air outlet, - two hollow branches (9, 10) which extend the hollow body by branching off and which each comprise at least one opening, - said openings being configured to eject blown air into a direction, substantially perpendicular to a plane P passing through the two branches (9, 10), and which cut the two branches by extending parallel to the latter, - said branches being configured such that the ends (12, 13) thereof between them have a clearance E making it possible for the passing of hair,
A method of predicting the response of a subject having, suspected of having, or at risk of developing, a differentiated thyroid cancer to a therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof, the method comprising: providing a first blood sample obtained from the subject before the therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof; providing a second blood sample obtained from the subject after initiation of the therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof; measuring the concentration of thyroglobulin in the first blood sample and the second blood sample; and calculating the ratio second/first of the concentrations of thyroglobulin, wherein a reduced ratio, as compared to a control, of the concentration of thyroglobulin in the blood samples is predictive that the subject will respond to a therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof, and wherein an increased ratio, as compared to a control, of the concentration of thyroglobulin in the blood samples is predictive that the subject will respond less effectively to the therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof than a subject having a reduced ratio, as compared to a control, of the concentration of thyroglobulin in the blood samples. providing a first blood sample obtained from the subject before the therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof; providing a second blood sample obtained from the subject after initiation of the therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof; measuring the concentration of thyroglobulin in the first blood sample and the second blood sample; and calculating the ratio second/first of the concentrations of thyroglobulin, wherein a reduced ratio, as compared to a control, of the concentration of thyroglobulin in the blood samples is predictive that the subject will respond to a therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof, and wherein an increased ratio, as compared to a control, of the concentration of thyroglobulin in the blood samples is predictive that the subject will respond less effectively to the therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof than a subject having a reduced ratio, as compared to a control, of the concentration of thyroglobulin in the blood samples.
A single-use, disposable mouth-cleaning device for a pet, comprising: a base; a side wall extending from the base, wherein the base and the side wall at least partially define an internal volume configured to receive a product; a plurality of protrusions (112, 122) extending from the base and the side wall, wherein the plurality of protrusions (112, 122) are configured to engage an oral tissue of a pet characterized in that a lid is coupled to the side wall by the manufacturer via threaded connection, using heat and pressure or using ultrasound, wherein the base, the side wall, and the lid at least partially define an internal volume; and a product disposed and sealed within the internal volume by the manufacturer. a base; a side wall extending from the base, wherein the base and the side wall at least partially define an internal volume configured to receive a product; a plurality of protrusions (112, 122) extending from the base and the side wall, wherein the plurality of protrusions (112, 122) are configured to engage an oral tissue of a pet characterized in that a lid is coupled to the side wall by the manufacturer via threaded connection, using heat and pressure or using ultrasound, wherein the base, the side wall, and the lid at least partially define an internal volume; and a product disposed and sealed within the internal volume by the manufacturer.